Collaboration. Innovation. Disruption.By Jamie Smith - 28 Aug 2018
Collaboration, innovation and disruption were in focus when the West Sweden Chamber of Commerce recently visited the BioVentureHub at AstraZeneca.
Matti Ahlqvist, Site Manager at AstraZeneca, set the scene and described how AstraZeneca is opening up to meet the future with new forms of collaboration with external parties.
Magnus Björsne, CEO for the BioVentureHub, described the smart way in which the BioVentureHub is offering small life science companies unique access to AstraZeneca's world-class life science industry knowledge, capabilities and infrastructure - using and sharing existing resources in new ways.
BioVentureHub company, Cellink, demonstrated their bioprinter at the event and met with happy visitors who got to make their own bioprint!